English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/88107
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


A Link between Autophagy and the Pathophysiology of LRRK2 in Parkinson’s Disease

AuthorsGómez-Suaga, P.; Fdez, E.; Blanca Ramírez, Marian; Hilfiker, Sabine
Issue DateNov-2012
PublisherHindawi Publishing Corporation
CitationParkinson's Disease
AbstractParkinson's disease is a debilitating neurodegenerative disorder, and its molecular etiopathogenesis remains poorly understood. The discovery of monogenic forms has significantly advanced our understanding of the molecular mechanisms underlying PD, as it allows generation of cellular and animal models carrying the mutant gene to define pathological pathways. Mutations in leucine-rich repeat kinase 2 (LRRK2) cause dominantly inherited PD, and variations increase risk, indicating that LRRK2 is an important player in both genetic and sporadic forms of the disease. G2019S, the most prominent pathogenic mutation, maps to the kinase domain and enhances enzymatic activity of LRRK2, which in turn seems to correlate with cytotoxicity. Since kinases are druggable targets, this has raised great hopes that disease-modifying therapies may be developed around modifying LRRK2 enzymatic activity. Apart from cytotoxicity, changes in autophagy have been consistently reported in the context of G2019S mutant LRRK2. Here, we will discuss current knowledge about mechanism(s) by which mutant LRRK2 may regulate autophagy, which highlights additional putative therapeutic targets.
Publisher version (URL)http://www.hindawi.com/journals/pd/2012/324521/
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
A link between.pdf1,61 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.